Methylene blue and cirrhosis: pathophysiologic insights, therapeutic dilemmas.
Fallon
M B
MB
D018450:Disease Progression; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D006162:Guanylate Cyclase / Q000037:antagonists & inhibitors*; D020065:Hepatopulmonary Syndrome / Q000188:drug therapy* / Q000473:pathology / Q000503:physiopathology; D006801:Humans; D008103:Liver Cirrhosis / Q000188:drug therapy* / Q000503:physiopathology; D008751:Methylene Blue / Q000627:therapeutic use*; D009569:Nitric Oxide / Q000502:physiology
D004791:Enzyme Inhibitors; D009569:Nitric Oxide; D006162:Guanylate Cyclase; D008751:Methylene Blue